20 Posts Not To Miss From IACH2024

The 7th Annual Meeting of the International Academy for Clinical Hematology (IACH), featuring the COMydAL, COLYM, and MPNCo&D tracks, is organized by CME Congresses Ltd. The event took place from September 19 to 21, 2024, at the Pullman Paris Tour Eiffel in Paris, Ile-de-France, France.

Doctors and healthcare professionals shared posts on this occasion:

Mohamed Kharfan-Dabaja:

“Managing hepatic sinusoidal obstruction syndrome in the setting of allogeneic hematopoietic cell transplantation in children by Selim Corbacioglu at the IACH2024 in Paris.”

Naveen Pemmaraju:

“Wonderful talk and panel discussion and great progress in latest updates in Systemic Mastocytosis by Dr. Deepti Radia during our MPNCo&D Congress Track of IACH2024.”

Mohamed Kharfan-Dabaja:

“Management of severe transplant-associated thrombotic microangiopathy (TA-TMA) by Iman Aboudalle from the American University of Beirut at the IACH2024 in Paris.”

Talha Badar:

“Christoph Röllig presents risk stratification in elderly AML.”

Lilija Banceviča:

“This week I wonderfully spent time in Paris, France whilst attending the International Academy for Clinical Hematology (IACH) 7th annual meeting. I was pleased to touch up with superb professors and doctors in hematology field, as well as improved my knowledge in multiple hematology topics. Thank you for having me and probably until next time!”

Mohamed Kharfan-Dabaja:

“Excellent overview on management of severe cytokine release syndrome following CAR T-cell therapy by Razan Mohty
from University of Alabama at Birmingham at the IACH2024.”

Mohamad Mohty:

“Dr. Emma Cookson senior editor at ⁦The Lancet Haematology introducing ⁦IACH special session dedicated to emotional and sexual life in patients with blood cancers. Thank you for tackling such an important, but usually neglected topic.”

Mohamed Kharfan-Dabaja:

“Excellent presentation about front-line management of mantle cell lymphoma by Madiha Iqbal at IACH2024, COLYM in Paris.”

Talha Badar:

“Prof. Harrison gave great presentation on management of high risk ET at The IACH.”

Mohamad Mohty:

“A very special and unique session to start the 2nd day of ⁦The IACH program. Please join us in person or virtually.”

Ruben Mesa:

“From MPNCo&D Congress toCOLYM Congress and MPNs to Hodgkin’s Disease glad to join friend and Atrium Health,
Levine Cancer colleague Nilanjan Ghosh at the IACH congress.”

Naveen Pemmaraju:

“So many nice MPN talks to kick off MPNCo&D Congress, IACH! Dr. Tania Jain, Adam Mead and FlorianHeidel!”

Mohamad Mohty:

“Welcome to ⁦The IACH meeting online and in-person.”

Mohamed Kharfan-Dabaja:

“Outstanding presentation on management of relapsed/refractory mantle cell lymphoma by Amer Beitinjaneh at IACH2024.”

Naveen Pemmaraju:

“Today, I was honored to receive the prestgious IACH International Academy for Clinical Hematology (IACH) 2024 Special Achievement Award!

Thank you to Prof. Mohamad Mohty and Prof. Arnon Nagler and the entire IACH team for their continued support and recognition of my work in hashtag BPDCN and MPN.

Speical Thanks Prof. Leukemia Department – Hagop Kantarjian, M.D. and Mary E. Silverstein and Department of Leukemia MD Anderson Cancer Center for all of their long-time career support.

Thanks to my co-moderators/co-founders for the MPNCo&D track of IACH Prof. Ruben Mesa, MD and Prof. Claire Harrison for their support in MPNSM!”

Abdulrahman Nasiri:

“Proud to share that two of our research abstracts have been accepted at the 7th Annual Meeting of the International Academy for Clinical Hematology (IACH)!

These studies reflect ongoing efforts to advance understanding in the fields of Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and Sickle Cell Disease (SCD), presented under the prestigious COMydAL, COLYM, and MPNCo&D tracks.

1.’Unique Progression from Blastic Plasmacytoid Dendritic Cell Neoplasm to Acute Myeloid Leukemia: A Case Report’

This is the first reported case in the world documenting the progression of BPDCN into acute myeloid leukemia (AML), highlighting the importance of vigilant monitoring and repeated immunophenotyping in managing this rare and aggressive neoplasm.

2.’The Outcome of Patients with Sickle Cell Disease Post-Hematopoietic Stem Cell Transplantation: A Retrospective Study in Riyadh, Saudi Arabia’

A comprehensive retrospective study of 139 SCD patients who underwent HLA-identical sibling HSCT between 2013 and 2023. The results demonstrate high survival rates and manageable toxicity profiles, offering hope for broader therapeutic applications.

Looking forward to sharing our findings with the international hematology community at this exciting event!”

Marwa Ahmad:

“Excited to have presented at the 7th Annual Meeting of the International Academy for Clinical Hematology (IACH) in Paris. My talk covered a challenging case of Mantle Cell Lymphoma (MCL) presenting in leukemic phase, with atrial fibrillation, retinal hemorrhage, and GI bleeding—highlighting some of the significant therapeutic challenges encountered.

I am grateful for the opportunity to share this complex case and learn from the exceptional discussions and insights from the global hematology community and experts.

Special thanks to my co-authors and mentors for their support in this endeavor: A. Sultan Alolama, P. Dutta, and M. Burney.”

Victor Tomacinschii:

“I am extremely honored to represent the Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova and the Institute of Oncology of Moldova at the proceedings of the 7th Annual Meeting of the International Academy for Clinical Hematology (IACH) which is takingplace between September 19-21, 2024 in Paris.

Many thanks to Professor Mohamad Mohty and the IACH organizing committee for the opportunity to be a part of this grand event.”

Zahra Al-Haj Issa:

“I am really glad to have attended the 7th IACH24 Annual Meeting and had the opportunity to present a poster (more details coming in the next post). The sessions covered intriguing and sometimes controversial topics, with panel discussions that were highly engaging.

The sessions were especially valuable, as many were delivered/moderated by the lead authors of key studies in their fields.

I also had the great pleasure of meeting and speaking with several doctors whose work I’ve been closely following, particularly Prof. Mohamad Mohty, the chairman of IACH. Dr. Mohty’s passion for education and sharing knowledge is truly remarkable.

Already looking forward to the next annual meeting and the chance to visit Paris again!”

Shahram Kordasti:

“I really enjoyed this year’s International Academy for Clinical Hematology (IACH) meeting in Paris. There were lots of great talks and discussions, and hopefully, new collaborations and projects will emerge to improve patient outcomes.”

More posts featuring IACH on oncodaily.com